Locus-specific HLA matching and induction therapy in simultaneous pancreas-kidney transplantation: a national UK cohort study. (PubMed, Transpl Int) - Sep 25, 2026 - "No significant survival difference was seen between Alemtuzumab and Basiliximab induction therapy. Induction therapy and HLA-mismatch status were not associated with pancreas graft outcome in this large registry study."
Journal • Retrospective data • Transplantation
|
|
Abdullah K Malik; Anand Muthasamy; Andrew Sutherland; Chris J Callaghan; Claire Counter; Colin H Wilson; David Van Dellen; Derek M Manas; Doruk Elker; Gavin J Pettigrew; Jenni Banks; John Casey; Lewis Simmonds; Martin Drage; Neil Russell; Neil S Sheerin; Samuel J Tingle; Sanjay Sinha; Steven A White
|